AZmed vs Rayscape (2026)
Two European plain radiograph companies pointed at different films. AZmed is trauma first, detecting fractures, joint effusions and dislocations, which is the highest volume plain radiograph reading in any emergency department and the one where a missed finding most reliably becomes a complaint. Rayscape is chest first, with a large findings set, longitudinal comparison across prior scans and lung nodule work on computed tomography, plus independent evaluation in a tuberculosis screening setting. They barely overlap clinically, so a department choosing between them is really choosing which reading burden to attack: the overnight trauma queue or the chest backlog. Whichever you pick, ask for performance on your own case mix rather than the aggregate figure, because prevalence changes the false positive burden more than sensitivity does.
- It is built around trauma radiography specifically, covering fractures, joint effusions and dislocations, which is the highest volume and most error prone plain film reading in any emergency department.
- Depth in one reading task is a different proposition from breadth across a findings list, and trauma is where a missed finding most often becomes a claim.
- European clearance and deployment across emergency settings mean the product has been used under time pressure rather than in a reading room.
- Breadth on chest radiography is substantial with longitudinal comparison across prior scans, plus lung nodule work on computed tomography, so it reaches beyond a single body region.
- Independent evaluation in a tuberculosis screening context is a harder test than a reader study, which is more external validation than most vendors at this size hold.
- Both on premise and cloud integration are available, which matters where images must stay inside the institution.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AZmed and Rayscape are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | AZmed | Rayscape |
|---|---|---|
| Primary category | Radiology & Imaging AI | Radiology & Imaging AI |
| Founded | 2018 | 2019 |
| Headquarters | Paris, France | Timisoara, Romania |
| Website | azmed.co | rayscape.ai |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
AZmed
-
EHR / interoperability
AZmed's FDA cleared AZtrauma and AZchest X-ray apps are now available on the Rapid Enterprise Platform, which RapidAI says more than 2,500 hospitals use.
Source -
Clinical evidence
CHU de Reims, which has used AZmed's fracture detection on all patients since 2021, published an independent evaluation in Pediatric Radiology.
Source -
Regulatory / FDA
AZmed received its sixth FDA clearance, for AZchest to detect and localize pneumothorax and pleural effusion on chest radiographs.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Paris based imaging AI company whose Rayvolve suite reads plain radiographs: AZtrauma detects fractures, dislocations and joint effusions, AZchest covers chest findings including pneumothorax, pleural effusion and lung nodules, and AZmeasure and AZboneage add measurements and bone age. A second suite, Rayscan, detects lung nodules on CT.
Source: AI Health Index, August 2026
Romanian imaging AI company based in Timisoara whose Rayscape CXR analyzes chest X-rays, detecting and localizing 148 findings across 17 clinical classes, including tuberculosis, with bone suppressed views, an automatic cardiothoracic ratio and a normal or abnormal flag for worklist prioritization, and whose lung CT product detects nodules and compares them against a patient's prior scans. Its tuberculosis detection was evaluated independently in a South African tuberculosis prevalence survey published in The Lancet Digital Health in 2024.
Source: AI Health Index, August 2026
Questions buyers ask
How do AZmed and Rayscape work with the EHR?
For AZmed, the company reports use at more than 2,500 sites in more than 55 countries and 15.4 million X-rays analyzed in the last twelve months, and its clearances rested on studies at named US institutions, University Hospitals in Cleveland and SimonMed Imaging. It has also been distributed through third party cloud radiology workflow platforms, including RADIN.
Rayscape CXR integrates with the archive over DICOM, on premises or with a cloud archive, returning annotated images and structured outputs inside the native radiology viewer without a separate workspace, and sites can configure outputs, thresholds and visualization to their own reporting standards. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How are AZmed and Rayscape priced and sold?
In AZmed's case, the software has been sold both directly and through cloud radiology platforms. The company's scale figures, more than 2,500 sites in more than 55 countries, describe use, not price.
The company's site has a pricing and plans page, and its AWS Marketplace listing for Rayscape CXR shows a free subscription with no end date alongside a 30 day money back guarantee on the current annual term, which suggests a paid annual contract behind the listing without stating its price or unit. The product can be procured through the marketplace and directly. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How do AZmed and Rayscape handle patient data?
With AZmed, the home page describes SOC 2, GDPR and HIPAA compliant infrastructure. The privacy policy, approved in December 2025, covers the website, billing, prospecting and recruitment, with retention periods for those records only; it does not address images or outputs processed by Rayvolve or Rayscan.
In Rayscape's case, the company's AWS Marketplace listing describes the product as software as a service, which sits uneasily with data never leaving the institution, and nothing says which deployments the commitment covers. Support, diagnostic and incident access usually carries exceptions. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
What evidence is published for AZmed and Rayscape?
For AZmed, a 2026 multicenter analysis by Cohen and colleagues covers 258,373 X-rays from 100 centers in 26 countries.
With Rayscape, the paper carries the product's figures and how they compared with other software at the thresholds the survey used. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
These read different studies for different purposes and are compared here because both are European plain radiograph vendors that a hospital might see in the same evaluation. The comparison should be run per body region and per finding rather than on aggregate claims, since a trauma product and a chest product share almost no performance surface. Neither publishes a security attestation or pricing.
For any radiograph AI, prevalence and case mix in your own population determine the false positive burden more than the published sensitivity does, and neither vendor publishes performance stratified that way.